Foraviset
Biotechnology Research • 
Bnei Brak, Tel-Aviv District, Israel • 1-10 Employees
Company overview
| Headquarters | 5 Masada, 36th Floor, Bnei Brak, IL |
| Phone number | +972544663163 |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contacts at Foraviset
Jacob Marx
Ceo And General Counsel
Refael Barkan
Founder & Chairperson
Foraviset Email Formats
Foraviset uses 1 email format. The most common is {first name} (e.g., john@foraviset.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@foraviset.com | 100% |
About Foraviset
Foraviset Ltd. is a privately held, innovative pharmaceutical company dedicated to developing its proprietary drug, Raviset®, aimed at treating women suffering from pathological menstrual complications such as endometriosis, dysmenorrhea, and abnormal uterine bleeding (AUB). Endometriosis, which, according to the World Health Organization (WHO), affects up to 10% of women of reproductive age globally , is often underdiagnosed and presents significant treatment challenges for the medical community. There is an urgent need for a highly effective and safe therapy for endometriosis and other severe menstrual conditions. Raviset®, utilizing a novel mechanism of action, has emerged as a breakthrough therapy meeting this critical need.
Foraviset revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Foraviset has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Foraviset has never raised funding before.
United States
Morocco
United Kingdom
Frequently asked questions
4.8
40,000 users
